Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Claire Elizabeth Dawson is active.

Publication


Featured researches published by Claire Elizabeth Dawson.


Bioorganic & Medicinal Chemistry Letters | 2008

Antagonists of the human adenosine A2A receptor. Part 3 Design and synthesis of pyrazolo[3,4-d]pyrimidines, pyrrolo[2,3-d]pyrimidines and 6-arylpurines

Roger J. Gillespie; Ian A. Cliffe; Claire Elizabeth Dawson; Colin T. Dourish; Suneel Gaur; Allan M. Jordan; Antony R. Knight; Joanne Lerpiniere; Anil Misra; Robert Mark Pratt; Jonathan Richard Anthon Roffey; Gemma Caroline Stratton; Rebecca Upton; Scott Murray Weiss; Douglas S. Williamson

A series of pyrazolo[3,4-d]pyrimidine, pyrrolo[2,3-d]pyrimidine and 6-arylpurine adenosine A(2A) antagonists is described. Many examples were highly selective against the human A(1) receptor sub-type and were active in an in vivo model of Parkinsons disease.


Bioorganic & Medicinal Chemistry Letters | 2008

Antagonists of the human adenosine A2A receptor. Part 2: Design and synthesis of 4-arylthieno[3,2-d]pyrimidine derivatives

Roger J. Gillespie; Ian A. Cliffe; Claire Elizabeth Dawson; Colin T. Dourish; Suneel Gaur; Paul R. Giles; Allan M. Jordan; Antony R. Knight; Anthony Lawrence; Joanne Lerpiniere; Anil Misra; Robert Mark Pratt; Richard S. Todd; Rebecca Upton; Scott Murray Weiss; Douglas S. Williamson

We describe herein the discovery and development of a series of 4-arylthieno[3,2-d]pyrimidines which are potent adenosine A(2A) receptor antagonists. These novel compounds show high degrees of selectivity against the human A(1), A(2B) and A(3) receptor sub-types. Moreover, a number of these compounds show promising activity in vivo, suggesting potential utility in the treatment of Parkinsons disease.


Archive | 2000

Thieno-and furopyrimidine derivatives as A2A-receptor antagonists

Roger John Gillespie; Joanne Lerpiniere; Paul R. Giles; Claire Elizabeth Dawson; David Bebbington


Archive | 1999

Indoline derivatives as 5-ht2b and/or 5-ht2c receptor ligands

David Reginald Adams; Jonathan Mark Bentley; Jonathan Richard Anthony Roffey; Richard John Hamlyn; Suneel Gaur; Matthew Duncton; David Bebbington; Nathaniel Julius Monck; Claire Elizabeth Dawson; Robert Mark Pratt; Ashley Roger George


Bioorganic & Medicinal Chemistry Letters | 2004

Indoline derivatives as 5-HT2C receptor agonists

Jonathan Mark Bentley; David R. Adams; David Bebbington; Karen Benwell; Michael John Bickerdike; J. E. P. Davidson; Claire Elizabeth Dawson; Colin T. Dourish; M. A. J. Duncton; Suneel Gaur; Ashley Roger George; Paul R. Giles; R. J. Hamlyn; Guy A. Kennett; Antony R. Knight; Craig S. Malcolm; Howard Langham Mansell; Anil Misra; N. J. T. Monck; Robert Mark Pratt; Kathleen Quirk; Jonathan Richard Anthon Roffey; Steven P. Vickers; Ian A. Cliffe


Archive | 2004

Azetidinecarboxamide derivatives and their use in the treatment of cb1 receptor mediated disordrs

James Edward Paul Davidson; Jonathan Mark Bentley; Claire Elizabeth Dawson; Kerry Harrison; Howard Langham Mansell; Alan Leslie Pither; Robert M. Pratt; Jonathan Richard Anthony Roffey; Victoria Jane Ruston


Bioorganic & Medicinal Chemistry Letters | 2008

Antagonists of the human adenosine A2A receptor. Part 1: Discovery and synthesis of thieno[3,2-d]pyrimidine-4-methanone derivatives

Roger J. Gillespie; David R. Adams; David Bebbington; Karen Benwell; Ian A. Cliffe; Claire Elizabeth Dawson; Colin T. Dourish; Allan Fletcher; Suneel Gaur; Paul R. Giles; Allan M. Jordan; Antony R. Knight; Lars Jacob Stray Knutsen; Anthony Lawrence; Joanne Lerpiniere; Anil Misra; Richard Hugh Philip Porter; Robert Mark Pratt; Robin Shepherd; Rebecca Upton; Simon E. Ward; Scott Murray Weiss; Douglas S. Williamson


Archive | 2002

Purine derivatives as purinergic receptor antagonists

Roger John Gillespie; Joanne Lerpiniere; Claire Elizabeth Dawson; Suneel Gaur; Robert Mark Pratt; Gemma Caroline Stratton; Scott Murray Weiss


Archive | 2002

Thieno(3,2-d)pyrimidines and furano(3,2-d)pyrimidines and their use as purinergic receptor antagonists

Roger John Gillespie; Joanne Lerpiniere; Claire Elizabeth Dawson; Suneel Gaur; Robert Mark Pratt


Archive | 2006

Morpholines as 5ht2c agonists

Jonathan Mark Bentley; Claire Elizabeth Dawson; Wolfgang Guba; Paul Hebeisen; Nathaniel Julius Monck; Robert Mark Pratt; Hans Richter; Stephan Roever; Vicki Ruston

Collaboration


Dive into the Claire Elizabeth Dawson's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Robert M. Pratt

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge